241 related articles for article (PubMed ID: 24933320)
1. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.
Nikitorowicz-Buniak J; Shiwen X; Denton CP; Abraham D; Stratton R
J Invest Dermatol; 2014 Nov; 134(11):2693-2702. PubMed ID: 24933320
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis.
Aden N; Nuttall A; Shiwen X; de Winter P; Leask A; Black CM; Denton CP; Abraham DJ; Stratton RJ
J Invest Dermatol; 2010 Sep; 130(9):2191-200. PubMed ID: 20445556
[TBL] [Abstract][Full Text] [Related]
3. Dysfunctional Keratinocytes Increase Dermal Inflammation in Systemic Sclerosis: Results From Studies Using Tissue-Engineered Scleroderma Epidermis.
Russo B; Borowczyk J; Boehncke WH; Truchetet ME; Modarressi A; Brembilla NC; Chizzolini C
Arthritis Rheumatol; 2021 Jul; 73(7):1311-1317. PubMed ID: 33497035
[TBL] [Abstract][Full Text] [Related]
4. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
5. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
[TBL] [Abstract][Full Text] [Related]
6. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
7. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Russo B; Borowczyk J; Cacialli P; Moguelet P; Truchetet ME; Modarressi A; Brembilla NC; Bertrand J; Boehncke WH; Chizzolini C
Rheumatology (Oxford); 2022 Nov; 61(11):4558-4569. PubMed ID: 35171244
[TBL] [Abstract][Full Text] [Related]
8. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
9. Contribution of keratinocytes to dermal fibrosis.
Russo B; Brembilla NC; Chizzolini C
Curr Opin Rheumatol; 2022 Nov; 34(6):337-342. PubMed ID: 35994728
[TBL] [Abstract][Full Text] [Related]
10. S100A8 and S100A9 Are Induced by Decreased Hydration in the Epidermis and Promote Fibroblast Activation and Fibrosis in the Dermis.
Zhong A; Xu W; Zhao J; Xie P; Jia S; Sun J; Galiano RD; Mustoe TA; Hong SJ
Am J Pathol; 2016 Jan; 186(1):109-22. PubMed ID: 26597884
[TBL] [Abstract][Full Text] [Related]
11. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
[TBL] [Abstract][Full Text] [Related]
12. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate.
Pannu J; Asano Y; Nakerakanti S; Smith E; Jablonska S; Blaszczyk M; ten Dijke P; Trojanowska M
Arthritis Rheum; 2008 Aug; 58(8):2528-37. PubMed ID: 18668566
[TBL] [Abstract][Full Text] [Related]
13. S100A8 and S100A9 are messengers in the crosstalk between epidermis and dermis modulating a psoriatic milieu in human skin.
Lee Y; Jang S; Min JK; Lee K; Sohn KC; Lim JS; Im M; Lee HE; Seo YJ; Kim CD; Lee JH
Biochem Biophys Res Commun; 2012 Jul; 423(4):647-53. PubMed ID: 22683330
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.
Leask A
Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of cav-1 in a subset of SSc fibroblasts contributes to constitutive Alk1/Smad1 activation.
Haines P; Hant FN; Lafyatis R; Trojanowska M; Bujor AM
J Cell Mol Med; 2012 Sep; 16(9):2238-46. PubMed ID: 22277251
[TBL] [Abstract][Full Text] [Related]
16. Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis.
Makino K; Makino T; Stawski L; Lipson KE; Leask A; Trojanowska M
Arthritis Res Ther; 2017 Jun; 19(1):134. PubMed ID: 28610597
[TBL] [Abstract][Full Text] [Related]
17. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
18. Suppressive Regulation by MFG-E8 of Latent Transforming Growth Factor β-Induced Fibrosis via Binding to αv Integrin: Significance in the Pathogenesis of Fibrosis in Systemic Sclerosis.
Fujiwara C; Uehara A; Sekiguchi A; Uchiyama A; Yamazaki S; Ogino S; Yokoyama Y; Torii R; Hosoi M; Suto C; Tsunekawa K; Murakami M; Ishikawa O; Motegi SI
Arthritis Rheumatol; 2019 Feb; 71(2):302-314. PubMed ID: 30175895
[TBL] [Abstract][Full Text] [Related]
19. Induction of matrix metalloproteinase-1 by small interfering RNA targeting connective tissue growth factor in dermal fibroblasts from patients with systemic sclerosis.
Ishibuchi H; Abe M; Yokoyama Y; Ishikawa O
Exp Dermatol; 2010 Aug; 19(8):e111-6. PubMed ID: 20653770
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
